Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
1.690
+0.030 (1.81%)
At close: Nov 22, 2024, 4:00 PM
1.700
+0.010 (0.59%)
After-hours: Nov 22, 2024, 7:43 PM EST
Protalix BioTherapeutics Market Cap
Protalix BioTherapeutics has a market cap or net worth of $124.44 million as of November 22, 2024. Its market cap has increased by 13.75% in one year.
Market Cap
124.44M
Enterprise Value
102.72M
1-Year Change
13.75%
Ranking
Category
Stock Price
$1.69
Market Cap Chart
Since December 1, 1998, Protalix BioTherapeutics's market cap has increased from $11.80M to $124.44M, an increase of 954.58%. That is a compound annual growth rate of 9.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 124.40M | -4.23% |
| Dec 29, 2023 | 129.90M | 87.18% |
| Dec 30, 2022 | 69.40M | 83.11% |
| Dec 31, 2021 | 37.90M | -68.68% |
| Dec 31, 2020 | 121.00M | 148.46% |
| Dec 31, 2019 | 48.70M | 5.64% |
| Dec 31, 2018 | 46.10M | -50.11% |
| Dec 29, 2017 | 92.40M | 107.64% |
| Dec 30, 2016 | 44.50M | -56.29% |
| Dec 31, 2015 | 101.80M | -40.95% |
| Dec 31, 2014 | 172.40M | -52.64% |
| Dec 31, 2013 | 364.00M | -24.96% |
| Dec 31, 2012 | 485.10M | 14.93% |
| Dec 30, 2011 | 422.10M | -47.92% |
| Dec 31, 2010 | 810.50M | 58.46% |
| Dec 31, 2009 | 511.50M | 266.14% |
| Dec 31, 2008 | 139.70M | -45.71% |
| Dec 31, 2007 | 257.30M | 2,552.58% |
| Dec 29, 2006 | 9.70M | -21.77% |
| Dec 30, 2005 | 12.40M | 1,671.43% |
| Dec 31, 2004 | 700.00K | -41.67% |
| Dec 31, 2003 | 1.20M | 300.00% |
| Dec 31, 2002 | 300.00K | -57.14% |
| Dec 31, 2001 | 700.00K | - |
| Dec 29, 2000 | 700.00K | -82.50% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coherus BioSciences | 125.58M |
| Telomir Pharmaceuticals | 125.55M |
| Cardiff Oncology | 125.28M |
| Eupraxia Pharmaceuticals | 125.04M |
| Skye Bioscience | 124.99M |
| InflaRx | 122.48M |
| Cibus | 122.41M |
| Zentek | 122.01M |